Microcapsule Market by Technology, End-user Industry, Shell Material, Core Material & Region

By -

The market size of microcapsule is estimated at USD 8.4 billion in 2021 and is projected to reach USD 13.4 billion by 2026, at a CAGR of 9.8% from 2021 to 2026.

(EMAILWIRE.COM, September 25, 2021 ) The microcapsule market is projected to grow from USD 8.4 billion in 2021 to USD 13.4 billion by 2026, at a CAGR of 9.8% from 2021 to 2026, owing to increasing demand from the pharmaceuticals & healthcare industry. The household and personal care industry is expected to register the highest CAGR from 2021 to 2026. The high growth of the household and personal care industry is due to the rising spending on personal care products by consumers across the world.

♦ Download Detailed PDF Brochure Here: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24415649

The key market players in the microcapsule market are BASF SE (Germany), Syngenta Crop Protection AG (Switzerland), Royal FrieslandCampina N.V. (Netherlands), Koninklijke DSM N.V. (Netherlands), Givaudan S.A. (Switzerland), Firmenich S.A. (Switzerland), Symrise AG (Germany), International Flavors & Fragrances (US), Lycored Corp. (Israel), and Sensient Technologies Corporation (US). These players have adopted expansions, acquisitions, product launches, investments, partnerships, joint ventures, mergers, collaborations, agreements, and divestments as their growth strategies to meet the growing demand for microcapsules.

BASF SE, is the leading player in the global microcapsule market. In August 2018, BASF SE’s animal nutrition division launched the Lucantin NXT product line in the European Union, which would be gradually followed in other countries. The carotenoid formulation of Lucantin NXT met the regulation (EC) No. 2017/962, which requires the withdrawal of ethoxyquin (EQ) as a feed additive. The product launch helped the company expand and strengthen its geographical footprint in the microcapsule animal nutrition market.

♦ Speak To Analyst – https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=24415649

Another important player in the global microcapsule market is Givaudan S.A. In May 2019, Givaudan S.A. launched Spherulite R10, a microencapsulated stabilized retinol. This product is manufactured using a microencapsulation technology called spherulite technology that offers faster and superior anti-aging clinical efficacy than free retinol. The product development helped the company to enhance its position in the beauty industry on a global level.

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more